CNS Metastasis Meeting - Saturday, February 27, 2027
Note that the programme is subject to change and will be continuously updated.
All times are in Central European Summer Time (CEST).
08:30-10:00
Abstract Presentations: Trials in Progress
LMD trials: lessons learned and future developments
Emilie Le Rhun, Switzerland
Clinical trial participation: the patient perspective
Eva Schumacher, Germany
10:00-10:30 Coffee Break
10:30-12:00
A critical view on elibility criteria of CNS metastasis trials
Matthias Preusser, Austria
A critical view on endpoints of CNS metastasis trials
Michael Weller, Switzerland
Incorporating brain metastasis heterogeneity in CNS metastasis trials
Manuel Valiente, Spain
The future of CNS metastases research: challenges and opportunities
Sanjay Popat, United Kingdom